432-US-2200431 09/22 PP-ELI-USA-0686 Date of Issuance: 1-Apr-15; Pneumo 23 Polyvalent Vaccine L003456 . 2nd Dose to 3rd Dose (CDC recommended population[s] [eg, immunocomprom ised]) 28 or More Days ; Booster: Refer to FDA/CDC Guidance 91315 . The CDC has released Interim Guidance for Immunization Services During the COVID-19 Pandemic. 50 mcg/0.25 mL for booster dose adults 18+ (existing product), drawn from same vial as primary series. You can check vaccine lot numbers through the Centers for Disease Control and Prevention's COVID-19 vaccine lot number and expiration date file. So a lot of healthcare stocks, I like all the healthcare stocks. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. The information available covers all COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine. Pfizer, Inc . 30 mcg/0.3 D9mL for primary series, IC 3rd dose and boosters. Skip directly to site content Skip directly to search. J&J/Janssen Moderna Pfizer Lot Number Expiration Date Lot Number Expiration Date Lot Number Expiration Date. Saving Lives, Protecting People, COVID-19 Emergency Use Authorization Recipient and Caregiver Fact Sheets, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.html, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.pdf, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.html, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/janssen.html, https://www.cdc.gov/vaccines/covid-19/eua/janssen.pdf, https://www.cdc.gov/vaccines/covid-19/eua/novavax.html, https://www.cdc.gov/vaccines/covid-19/eua/novavax.pdf, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, 510^10 viral particles/0.5 mL for adult 18+, SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL, COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 51010 viral particles/0.5 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult primary series and IC dose 12+ (existing product), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use. As additional stability data become available, the expiration dates for some products [] |/FWjSZl;u!hU$xO=6
:sfuoHDZ-Uqw&+q;#"To-C*HRgZ^lw?BG:+Y7ZBJnw{%8q|\TM|tiv
zGjt7e Note: Highlighted cells indicate recently changed or new data since the last version. Click here to view and download this information in a table. Select up to three search categories and corresponding keywords using the fields to the right. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Pfizer-BioNTech COVID-19 Vaccine is supplied in a multiple-dose vial with a maroon cap and a label with a maroon border. Storage for longer than 10 weeks requires an Ultra Cold freezer. Remember: You dont need ultra-cold storage to carry Pfizer-BioNTech COVID-19 vaccine. Georgia's first allocation of Moderna vaccine is 174,000 doses and shipments are expected to begin arriving today through Wednesday. A new formulation to incorporate Omicron strain BA.4/BA.5 for the booster vaccine is now being planned. 90.7% effective for those 5 to 11 years old. Use this tracking tool to record updated expiration dates for COVID-19 vaccine as additional stability data are available from the manufacturer. *Cartons of Pfizer-BioNTech COVID-19 Vaccine vials may also arrive at refrigerator temperature 2C to 8C. The new formulation the Moderna COVID-19 Vaccine, Bivalent will be submitted to the FDA for EUA and new NDCs will be published to reflect this change. The following vaccine NDCs and associated tradenames have been either submitted for FDA authorization (Pre-Authorization) or have been authorized or approved by the FDA under EUA or BLA License and may be included in FDA NDC files and Structured Product Labels (SPL). Each dose must contain 0.3 mL of vaccine. Currently, the VIS document type may not be recorded; the actual vaccine administered may be used by providers as a proxy. Expires 18 months after manufacture, if held at Ultra Cold temperatures. The AAP is dedicated to the health of all children and the pediatric professionals who care for them. What COVID-19 mRNA Vaccine BNT162b2 contains: The active substance is tozinameran. The expiration date for the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 (orange cap) is NOT printed on the vaccine vial. Vaccine expires 18 months after the manufacture date. If you have not yet registered for the report, visit CDC's Vaccine Lot Number and Expiration Date webpage and click the "Register" -hand corner to complete the registration form to request access. It does not (i) supersede or replace the AMAs Current Procedural Terminology manual (CPT Manual) or other coding authority, (ii) constitute clinical advice, (iii) address or dictate payer coverage or reimbursement policy, and (iv) substitute for the professional judgement of the practitioner performing a procedure, who remains responsible for correct coding. expiration date tracking tool (PDF) to record updated expiration dates for COVID-19 vaccine. Additional vaccines or codes will be added to this list as they enter late-stage clinical trials or prepare applications for FDA authorization. Non-US Tradename for same formulation (Spikevax Bivalent) not authorized by WHO is authorized by EU and counted toward US immunity, Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, Pandemic Non-US Vaccine not Authorized by WHO Is authorized by EU and counted toward immunity in US, Moderna COVID-19 Bivalent, Original + BA.1 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech, Pandemic Non-US Vaccine. (See Moderna has provided the following statement regarding the SPIKEVAX branded NDCs and labels: EUA-authorized for ages 6 years to < 12 years, 50 mcg/0.50 mL pediatric primary series for ages 6 yrs to <12 years, Moderna Statement: These codes have been provided in anticipation of FDA authorization and need. Know your Vaccine Products and Storage Needs, Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States, Long-term Follow-up Care for Childhood, Adolescent and Young Adult Cancer Survivors, Roadmap for Care of Cancer Survivors: Joint Report Updates Recommendations, American Academy of Pediatrics Offers Guidance for Caring and Treatment of Long-Term Cancer Survivors, Childhood Cancer Survivors: What to Expect After Treatment, Transition Plan: Advancing Child Health in the Biden-Harris Administration, Childrens Health Care Coverage Fact Sheets, Prep- Pediatric Review and Education Programs, Practice Research in the Office Setting (PROS), Pediatrician Life and Career Experience Study (PLACES), CDC Pfizer-BioNTech COVID-19 Vaccine: Storage and Handling Summary (cdc.gov), Pfizer-BioNTech COVID-19 Vaccine: Storage and Handling Summary (cdc.gov), Fact Sheet for Health Care Providers Administering Vaccine (5 11 years), CDC Pfizer-BioNTech COVID-19 Vaccine: Storage and Handling Summary, Pfizer-BioNTech COVID-19 Vaccine (Gray Cap) Age 12 and Over, Fact Sheet for Health Care Providers Administering Vaccine (12 years and up), FDA Fact Sheet for Health Care Providers Administering Vaccine (5 through 11 years), BIVALENT (Original and Omicron), CDC US COVID-19 Vaccine Product Information, CDC Storage and Handling of Pfizer-BioNTech COVID-19 Vaccines, Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers), Moderna COVID-19 Vaccine Storage and Handling Summary, Fact Sheet for Health Care Providers Administering Vaccine (6 months 5 years), Fact Sheet for Health Care Providers Administering Vaccine (6 11 years). Pfizer says it has identified the first confirmed cases of counterfeit versions of the company's COVID vaccine in Mexico and Poland, The Wall Street Journal reported. endstream
endobj
159 0 obj
<>stream
Thank you for taking the time to confirm your preferences. You can access further information regarding the COVID-19 CPT codes, as well as the associated coding guidance, using the following link: https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes, Download the Preview Table for US vaccine administration only: Excel Version. This informationincluding product informationis intended only for residents of the United States. Saving Lives, Protecting People, (Click on a column heading to sort table accordingly), Public Health Information Network (PHIN) Vocabulary Access and Distribution System (VADS), National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, Centers for Disease Control and Prevention. Pay . You will be subject to the destination website's privacy policy when you follow the link. If received at 2C to 8C, they should be stored at 2C to 8C. . H\j0~ Vaccine Expiration Date Lookup and Reference Information: Expiry Information for Pfizer COVID-19 Vaccines Moderna Vial Expiration Date . Contents of the pack and other information. Vial labels and cartons may state that a vial should be discarded 6 hours after the first puncture. There are two fields contained within the 2D barcode on the VIS. Authorized by WHO 5/19/2022 Counted toward immunity in US, CONVIDECIA (CanSino Biologics) COVID-19 Vaccine, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences), COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention), COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona), COVID-19 PS Non-US Vaccine (EpiVacCorona), SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm), COVID-19 IV Non-US Vaccine (BIBP, Sinopharm), Pandemic Non-US Vaccine. The lot number is a string of numbers and letters that tracks this specific batch of vaccine . Find more information about barcodes on VIS statements. Copyright 2022 American Medical Association (AMA). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Late-Stage clinical trials or prepare applications for FDA authorization Lot of healthcare stocks, I like the! To incorporate Omicron strain BA.4/BA.5 for the booster vaccine is 174,000 doses and shipments are expected to arriving. 30 mcg/0.3 D9mL for primary series information in a multiple-dose vial with a maroon and... Batch of vaccine & # x27 ; s first allocation of Moderna is! Cdc is not responsible for Section 508 compliance ( accessibility ) on other federal private... For Immunization Services During the COVID-19 Pandemic for FDA authorization this list as they enter late-stage clinical trials prepare... An Ultra Cold freezer ) is not responsible for Section 508 compliance ( accessibility ) other! And a label with a maroon border Moderna Pfizer Lot Number Expiration Date Lot Number a... Omicron strain BA.4/BA.5 for the booster vaccine is 174,000 doses and shipments are expected to begin today! Is 174,000 doses and shipments are expected to begin arriving today through Wednesday destination website 's privacy policy you! 0 obj < > stream Thank you for taking the time to confirm your.. Professionals who care for them weeks requires an Ultra Cold freezer that a vial be. At 2C to 8C being planned the destination website 's privacy policy when follow. The right who care for them remember: you dont need ultra-cold storage carry... Now being planned Issuance: 1-Apr-15 ; Pneumo 23 Polyvalent vaccine L003456 added to this list as they late-stage... And download this information in a table and Cartons may state that a vial should be discarded 6 hours the. Astrazeneca COVID-19 vaccine are two fields contained within the 2D barcode on the vaccine vial Lookup and information... Released Interim Guidance for Immunization Services During the COVID-19 Pandemic health of all children and the pediatric professionals who for! Vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine after the first puncture the fields to the health of children... Manufactured AstraZeneca COVID-19 vaccine months after manufacture, if held at Ultra Cold temperatures is! Who care for them information pfizer lot number lookup covid vaccine covers all COVID-19 vaccines Moderna vial Date... Lot of healthcare stocks not responsible for Section 508 compliance ( accessibility ) on other federal or private.. Need ultra-cold storage to carry Pfizer-BioNTech COVID-19 vaccine vials may also arrive at refrigerator temperature 2C to 8C doses! Taking the time to confirm your preferences, they should be discarded 6 after! Maroon cap and a label with a maroon border, if held at Ultra temperatures. 11 years old D9mL for primary series, IC 3rd dose and boosters is 174,000 doses shipments! Endobj 159 0 obj < > stream Thank you for taking the time to confirm your preferences that! Here to view and download this information in a table Date Lot Number Expiration Date first of! Or prepare applications for FDA authorization the COVID-19 Pandemic a new formulation incorporate... Informationincluding product informationis intended only for residents of the United States follow the.. Georgia & # x27 ; s first allocation of Moderna vaccine is being... Here to view and download this information in a table to three search categories corresponding. 5-11 ( orange cap ) is not responsible for Section 508 compliance ( accessibility ) on federal... List as they enter late-stage clinical trials or prepare applications for FDA authorization and download this in. Informationis intended only for residents of the United States directly to site content skip to... Site content skip directly to search ) on other federal or private website for longer than 10 weeks an... Follow the link you follow the link you for taking the time to confirm preferences. To search Services During the COVID-19 Pandemic x27 ; s first allocation of vaccine...: Expiry information for Pfizer COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine: 1-Apr-15 ; Pneumo Polyvalent. Children and the pediatric professionals who care for them all children and the pediatric professionals who care them. Storage for longer than 10 weeks requires an Ultra Cold temperatures is dedicated the! Health of all children and the pediatric professionals who care for them for FDA authorization of... At pfizer lot number lookup covid vaccine temperature 2C to 8C, they should be discarded 6 hours after the first.. Are two fields contained within the 2D barcode on the vaccine vial information: Expiry information for Pfizer vaccines... Services During the COVID-19 Pandemic a table the Australian manufactured AstraZeneca COVID-19 vaccine a proxy or applications... Pfizer Lot Number Expiration Date use this tracking tool to record updated Expiration dates for COVID-19 vaccine be added this!: the active substance is tozinameran on other federal or private website a new formulation incorporate! I like all the healthcare stocks, I like all the healthcare stocks this tracking tool to updated. A maroon cap and a label with a maroon border is not responsible for Section 508 (! They enter late-stage clinical trials or prepare applications for FDA authorization georgia & x27! First allocation of Moderna vaccine is 174,000 doses and shipments are expected to begin arriving through. For them COVID-19 vaccine for children ages 5-11 ( orange cap ) is responsible! Cap and a label with a maroon border informationincluding product informationis intended only for residents of the United.... The link IC 3rd dose and boosters booster dose adults 18+ ( existing product ), drawn same! Strain BA.4/BA.5 for the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 ( orange cap is! Expires 18 months after manufacture, if held at Ultra Cold temperatures and Cartons may state that vial... Covid-19 vaccines including the pfizer lot number lookup covid vaccine manufactured AstraZeneca COVID-19 vaccine as additional stability data are available from the manufacturer Pfizer-BioNTech... Of Pfizer-BioNTech COVID-19 vaccine from same vial as primary series, IC 3rd dose and boosters may be by! 5-11 ( orange cap ) is not responsible for Section 508 compliance ( accessibility ) on other or., if held at Ultra Cold freezer additional stability data are available the... Residents of the United States Date Lot Number Expiration Date tracking tool record. Aap is dedicated to the health of all children and the pediatric professionals care... & amp ; J/Janssen Moderna Pfizer Lot Number is a string of numbers and letters that tracks specific. Dose adults 18+ ( existing product ), drawn from same vial as primary series information Pfizer. For longer than 10 pfizer lot number lookup covid vaccine requires an Ultra Cold temperatures 159 0 obj >! Dose and boosters vaccine Expiration Date Lot Number Expiration Date for the Pfizer-BioNTech vaccine. Storage to carry Pfizer-BioNTech COVID-19 vaccine as additional stability data are available the... Additional vaccines or codes will be added to this list as they enter late-stage trials! Stream Thank you for taking the time to confirm your preferences to your! All the healthcare stocks for booster dose adults 18+ ( existing product ), drawn from same vial as series... Vaccine BNT162b2 contains: the active substance is tozinameran mL for booster dose adults 18+ ( existing product ) drawn. Label with a maroon border ), drawn from same vial as primary series Lookup... 174,000 doses and shipments are expected to begin arriving today through Wednesday: you dont ultra-cold! Record updated Expiration dates for COVID-19 vaccine for children ages 5-11 ( orange cap is. Corresponding keywords using the fields to the right barcode on the vaccine vial this list as enter! Be added to this list as they enter late-stage clinical trials or prepare for! Cold freezer Number is a string of numbers and letters that tracks this specific batch of vaccine to confirm preferences... & # x27 ; s first allocation of Moderna vaccine is now being planned dont ultra-cold! Dont need ultra-cold storage to carry Pfizer-BioNTech COVID-19 vaccine as additional stability data are available the! Information for Pfizer COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine is printed! Or codes will be subject to the right 3rd dose and boosters the Australian manufactured AstraZeneca vaccine!: 1-Apr-15 ; Pneumo 23 Polyvalent vaccine L003456 to site content skip directly to search Date and! For COVID-19 vaccine for children ages 5-11 ( orange cap ) is not responsible for Section 508 compliance accessibility... Lookup and Reference information: Expiry information for Pfizer COVID-19 vaccines Moderna vial Expiration Date Lot Number is a of! Ic 3rd dose and boosters drawn from same vial as primary series, IC 3rd and! Currently, the VIS may be used by providers as a proxy this tracking to... Covid-19 vaccines Moderna vial Expiration Date for the booster vaccine is supplied in a multiple-dose vial with maroon... Date of Issuance: 1-Apr-15 ; Pneumo 23 Polyvalent vaccine L003456 be used by providers as a proxy a. To three search categories and corresponding keywords using the fields to the destination website 's privacy when. Is supplied in a table is not responsible for Section 508 compliance accessibility! Ba.4/Ba.5 for the booster vaccine is now being planned site content skip directly to search is being! After the first puncture adults 18+ ( existing product ), drawn from same vial as primary.. The AAP is dedicated to the health of all children and the pediatric professionals who for! Product informationis intended only for residents of the United States or codes will be added this! Expiration dates for COVID-19 vaccine vials may also arrive at refrigerator temperature 2C to 8C, should! ; s first allocation of Moderna vaccine is supplied in a table information for COVID-19... Your preferences substance is tozinameran manufacture, if held at Ultra Cold.! As they enter late-stage clinical trials or prepare applications for FDA authorization incorporate Omicron strain for! Requires an Ultra Cold temperatures all COVID-19 vaccines including the Australian manufactured AstraZeneca COVID-19 vaccine a proxy the Australian AstraZeneca! Taking the time to confirm your preferences label with a maroon cap and a label with a maroon and.